Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis

scientific article published on 01 March 2001

Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/HUMREP/16.3.561
P698PubMed publication ID11228229

P2093author name stringT Tanaka
M Sasaki
S Igarashi
H Ota
P433issue3
P921main subjectendometriosisQ205764
P304page(s)561-566
P577publication date2001-03-01
P1433published inHuman ReproductionQ5937357
P1476titleDistribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis
P478volume16

Reverse relations

cites work (P2860)
Q34008026A conditionally replicative adenovirus, CRAd-S-pK7, can target endometriosis with a cell-killing effect
Q42380795Abnormal Expression of Prostaglandins E2 and F2α Receptors and Transporters in Patients with Endometriosis
Q26786756Adenomyosis and its impact on women fertility
Q35067602Anti-inflammatory, antiangiogenic, and apoptosis-inducing activity of DLBS1442, a bioactive fraction of Phaleria macrocarpa, in a RL95-2 cell line as a molecular model of endometriosis.
Q37326252Anti-platelet therapy holds promises in treating adenomyosis: experimental evidence
Q33903608Autotaxin-lysophosphatidic acid-LPA3 signaling at the embryo-epithelial boundary controls decidualization pathways
Q91712604Celecoxib, a selective COX-2 inhibitor, markedly reduced the severity of tamoxifen-induced adenomyosis in a murine model
Q47121869Complications and outcomes of pregnant women with adenomyosis in Japan
Q35581225Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium.
Q35547033Cyclooxygenase enzymes and prostaglandins in reproductive tract physiology and pathology.
Q92099145Cyclooxygenase-2 in Endometriosis
Q36341296DNA hypomethylation of the COX-2 gene promoter is associated with up-regulation of its mRNA expression in eutopic endometrium of endometriosis
Q36722241DNA methylation in endometriosis (Review).
Q37061095Deficiency of immunophilin FKBP52 promotes endometriosis
Q48690673Effects of prostaglandin E2 and vascular endothelial growth factor on sperm might lead to endometriosis-associated infertility
Q24185846Endometrial biomarkers for the non-invasive diagnosis of endometriosis
Q39365130Endometrial receptivity in the eutopic endometrium of women with endometriosis: it is affected, and let me show you why.
Q36855660Endometrial-peritoneal interactions during endometriotic lesion establishment
Q49884536Endometriosis and endometriosis-associated cancers: new insights into the molecular mechanisms of ovarian cancer development
Q35668144Endometriosis: alternative methods of medical treatment.
Q98613567Endometritis in the bitch: Immunohistochemical localization of cyclooxygenase 2
Q36194043Euterpe oleracea Extract (Açaí) Is a Promising Novel Pharmacological Therapeutic Treatment for Experimental Endometriosis
Q92184572Eutopic endometrium from patients with endometriosis modulates the expression of CD36 and SIRP-α in peritoneal macrophages
Q46567254Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer.
Q21203690Immunohistochemical analysis of an ectopic endometriosis in the uterine round ligament
Q77218175Increased expression of cyclooxygenase-2 in local lesions of endometriosis patients
Q36509755Inflammatory status influences aromatase and steroid receptor expression in endometriosis.
Q33597181Inhibition of CD36-dependent phagocytosis by prostaglandin E2 contributes to the development of endometriosis
Q35107985Lipoxin A₄ prevents the progression of de novo and established endometriosis in a mouse model by attenuating prostaglandin E₂ production and estrogen signaling
Q34362219Macrophage migration inhibitory factor is involved in ectopic endometrial tissue growth and peritoneal-endometrial tissue interaction in vivo: a plausible link to endometriosis development
Q53239739Medical Management of Endometriosis.
Q40049589NSAID resistance in dysmenorrhea: epidemiology, causes, and treatment.
Q35108926Noninvasive diagnosis of endometriosis: the role of imaging and markers
Q34636424Oxidative stress and peritoneal endometriosis
Q33936661Possible Loss of GABAergic Inhibition in Mice With Induced Adenomyosis and Treatment With Epigallocatechin-3-Gallate Attenuates the Loss With Improved Hyperalgesia
Q26767444Recent advances in the understanding of endometriosis: the role of inflammatory mediators in disease pathogenesis and treatment
Q90027519Role of angiogenesis in adenomyosis-associated abnormal uterine bleeding and subfertility: a systematic review
Q33642212Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1/2, AKT, NFkappaB, and beta-catenin pathways and activation of intrinsic apoptotic mechanisms.
Q33581564Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits adhesion of human endometriotic epithelial and stromal cells through suppression of integrin-mediated mechanisms
Q36853935Surgical removal of endometriotic lesions alters local and systemic proinflammatory cytokines in endometriosis patients
Q36199231Telemetric assessment of referred vaginal hyperalgesia and the effect of indomethacin in a rat model of endometriosis
Q38192902The peritoneum--an important factor for pathogenesis and pain generation in endometriosis
Q24656185Up-regulation of cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic cells by macrophage migration inhibitory factor: involvement of novel kinase signaling pathways
Q43990128Up-regulation of cyclooxygenase-2 expression and prostaglandin synthesis in endometrial stromal cells by malignant endometrial epithelial cells. A paracrine effect mediated by prostaglandin E2 and nuclear factor-kappa B.
Q81442157[Adenomyosis: update on a frequent but difficult diagnosis]
Q52847220[Endometriosis : An often unrecognized pain disorder].

Search more.